U.S. markets closed
  • S&P Futures

    4,006.50
    -26.00 (-0.64%)
     
  • Dow Futures

    34,189.00
    -167.00 (-0.49%)
     
  • Nasdaq Futures

    11,690.50
    -92.25 (-0.78%)
     
  • Russell 2000 Futures

    1,856.90
    -13.30 (-0.71%)
     
  • Crude Oil

    74.43
    -1.85 (-2.43%)
     
  • Gold

    1,749.00
    -5.00 (-0.29%)
     
  • Silver

    21.18
    -0.25 (-1.14%)
     
  • EUR/USD

    1.0365
    -0.0040 (-0.38%)
     
  • 10-Yr Bond

    3.6910
    -0.0150 (-0.40%)
     
  • Vix

    20.50
    +0.08 (+0.39%)
     
  • GBP/USD

    1.2049
    -0.0042 (-0.35%)
     
  • USD/JPY

    138.4620
    -0.6380 (-0.46%)
     
  • BTC-USD

    16,159.79
    -342.14 (-2.07%)
     
  • CMC Crypto 200

    378.70
    -3.95 (-1.03%)
     
  • FTSE 100

    7,486.67
    +20.07 (+0.27%)
     
  • Nikkei 225

    28,103.55
    -179.48 (-0.63%)
     

Azenta to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

CHELMSFORD, Mass., Aug. 11, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2022.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As of December 1st, the company changed its name and ticker to Azenta, Inc. (Nasdaq: AZTA) from Brooks Automation, Inc, (Nasdaq: BRKS).

Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACT:
Sara Silverman
Head of Investor Relations
978.262.2635
IR@azenta.com

Sherry Dinsmore
Azenta Life Sciences
978.262.2400
sherry.dinsmore@azenta.com

Azenta logo (PRNewsfoto/Azenta)
Azenta logo (PRNewsfoto/Azenta)

 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-7th-annual-needham-virtual-med-tech--diagnostics-1x1-conference-301604577.html

SOURCE Azenta, Inc.